Immune booster after transplant shows promise for blood cancer patients
NCT ID NCT01853358
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tested whether giving specially selected donor immune cells (NK cells) soon after a stem cell transplant is safe for people with blood cancers. Seventeen patients received the cells, and researchers monitored for serious side effects within 30 days. The goal was to find a safer alternative to standard donor lymphocyte infusions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Paoli-Calmettes
Marseille, 13009, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a walk a day keep brain fog away after a stem cell transplant?
- Ancient herb, modern hope: ashwagandha compound tested to prevent deadly transplant complication
- Ancient herb takes on transplant complication: Withaferin-A tested for Steroid-Resistant GVHD
- New program helps caregivers of stem cell patients cope better
- New antibiotic could shield blood cancer patients from deadly infections
- Can a common asthma drug stop post-transplant fevers?